Symbol | Name | Allocation | Country | Exchange |
---|---|---|---|---|
ROG | Roche Holding AG | 16.12% | CH | SW |
AZN | Astrazeneca Plc | 14.63% | UK | LSE |
NOVO-B | Novo Nordisk A/S | 14.39% | DK | CO |
NOVN | Novartis AG | 13.49% | CH | SW |
GSK | Glaxosmithkline Plc | 4.84% | UK | LSE |
LONN | Lonza Group AG | 2.72% | CH | SW |
ALC | Alcon AG | 2.39% | CH | SW |
ARGX | Argen-X | 1.57% | BE | BR |
COLO-B | Coloplast A/S | 0.97% | DK | CO |
SOON | Sonova H Ag | 0.97% | CH | SW |
PHIA | Koninklijke Philips NV | 0.92% | NL | AS |
STMN | Straumann Holding AG | 0.90% | CH | SW |
SN | Smith & Nephew | 0.80% | UK | LSE |
QGEN | Qiagen N.V. | 0.79% | US | NYSE |
RO | Roche Holding AG | 0.75% | CH | SW |
UCB | UCB SA | 0.71% | BE | BR |
SRT3 | Sartorius Aktiengesellschaft | 0.63% | DE | XETRA |
FME | Fresenius Medical Care AG & Co. KGaA | 0.45% | DE | XETRA |
ORNBV | Orion Oyj B | 0.40% | FI | HE |
AFX | Carl Zeiss Meditec AG | 0.38% | DE | XETRA |